Life Sciences is transitioning to where more diseases are cured, treatments are personalized and patient/consumer preferences are at the center of decision-making. This future will be powered by deploying data science- and richer data from the external world- to drive the earnings growth that stakeholders and markets will continue to expect.
Featured insight
Restarting America: Data signals to help your business thrive
Reopen, rebuild and continue making strong business decisions with confidence in a COVID-19 world using the KPMG economic vibrancy analytics platform.